Global Med Technologies(R), Inc.'s CEO to Present at the Third Annual Maxim Group Growth Conference
September 25 2009 - 9:00AM
PR Newswire (US)
Global Med's New Transfusion Safety RFID Product to be Demoed
DENVER, Sept. 25 /PRNewswire-FirstCall/ -- Global Med Technologies
, Inc. ("Global Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD:
GLOB) , an international healthcare information technology company,
will present at the Third Annual Maxim Group Growth Conference.
Mick Ruxin, M.D., Chairman and CEO, is scheduled to present on
Tuesday, September 29, 2009, at 9:30 a.m. Eastern in the Imperial
Room of the Grand Hyatt Hotel in New York. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO Dr.
Ruxin will give a 25-minute presentation regarding Global Med's
business and discuss its unique value proposition, latest product
developments, including the verIDhemos system, which is Global
Med's recently announced innovative transfusion safety RFID product
(not for sale in the U.S.), as well as the Company's financial
performance and prospects. A question and answer session will
follow the presentation. The presentation will be Webcast live and
may be accessed by visiting:
http://www.wsw.com/webcast/maxim2/glob.ob/. A replay of the
presentation will also be available on Global Med's Website at
http://www.globalmedtech.com/ for 30 days following the
presentation. About Global Med Technologies , Inc. Global Med
Technologies, Inc. is an international healthcare information
technology company which develops regulated and non-regulated
products and services for the healthcare industry. As a leading
provider of blood and laboratory systems and services, Global Med's
products are deployed in 20 countries and serve over 2,100
transfusion centers, blood banks and laboratory sites. Global Med's
domestic companies are Wyndgate Technologies , a leader in software
products and services for donor centers and hospital transfusion
services; eDonor , which offers web-based donor relationship
management systems; and PeopleMed , Inc., which implements
cost-effective software validation, consulting and compliance
solutions to hospitals and donor centers. Global Med's European
subsidiary, Inlog, SA, is a leading developer of donor center and
transfusion management systems as well as cellular therapy
software, laboratory information systems and quality assurance
medical software systems internationally. For more information
about Global Med's products and services, please call 800-996-3428
or visit http://www.globalmedtech.com/. This news release may
include statements that constitute forward-looking statements,
usually containing the words "believe," "estimate," "project,"
"expects" or similar expressions. These statements are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements
inherently involve risks and uncertainties that could cause actual
results to differ materially from the forward-looking statements.
By making these forward-looking statements, the Company undertakes
no obligation to update these statements for revisions or changes
after the date of this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000; or Investors, Jeffrey Benison,
+1-212-334-8709, , for Global Med Technologies, Inc. Web Site:
http://www.globalmedtech.com/
Copyright